Download Latest CCDS-O Questions

In the outpatient setting, when the provider does not document a definitive diagnosis for the acute complaint (e.g., influenza, sinusitis, URI), ICD-10-CM guidance directs coders to report thesigns and symptomsthat are documented and addressed. Here, the clinician documentscongestion, fever, and malaiseand provides treatment instructions for those symptoms (OTC meds, rest, follow-up). That makes the symptom codes the most appropriate representation of the reason for the encounter. Outpatient CDI principles further emphasize that chronic conditions likeDM, GERD, and HTNshould only be coded when the documentation shows they wereevaluated, monitored, assessed/managed, or treatedduring the visit (e.g., status, control, medication adjustment, related testing, counseling). In this note, the plan targets only the acute symptoms and does not demonstrate active management of the chronic conditions beyond listing history/medications. Therefore, the guideline most directly applicable to correct coding of the encounter iscodes that describe symptoms and signs.

This encounter documents both hypertension and heart failure management, creating a key outpatient documentation/coding clarification opportunity: whether the heart failure is related to hypertension (hypertensive heart disease with heart failure). Outpatient CDI principles emphasize capturing the true clinical relationships that affect code assignment, risk adjustment, and longitudinal disease management. When HTN and HF coexist, coding may require combination coding and correct sequencing, plus an additional heart failure code to describe the specific HF type. Provider documentation that explicitly links (or explicitly rules out) a causal relationship supports compliant selection of the most accurate diagnosis codes and reduces ambiguity during chart review. The other options are weaker: the provider already documents HFrEF (type), and while added severity detail can help, the scenario’s primary clarification “opportunity” is the HTN–HF relationship. DM type 1 inherently involves insulin, so “insulin status” is not the key outpatient clarification point here, and there is no typical direct linkage between DM and arthritis supported by the note.

Metoprolol is a beta-blocker commonly used in atrial fibrillation to achieve ventricularrate control, reduce symptoms (palpitations, dyspnea), and improve hemodynamic stability, especially when the rhythm is persistent or recurrent. From an outpatient CDI chart-review perspective, therapy-to-diagnosis consistency is a key clinical indicator that supports clarifying the condition being treated and ensuring it is documented as assessed/managed at the encounter. The other options are clinically mismatched: “Ensure” is a nutritional supplement typically used for inadequate intake or weight loss and would not be recommended for morbid obesity; rivaroxaban (Xarelto) is an anticoagulant and would be inappropriate in the setting of hematemesis (active GI bleeding) where anticoagulation generally increases risk and would typically be held or reassessed; tamoxifen is an endocrine therapy for hormone receptor–positive breast cancer risk/treatment and is not a standard therapy for chronic congestive heart failure. Therefore, metoprolol for atrial fibrillation is the most appropriate and likely recommendation among the choices.

In outpatient CDI and coding guidance, an “uncertain diagnosis” is identified by wording that indicates the provider has not confirmed the condition (e.g., possible, probable, suspected, rule out, question of, concern for). These terms reflect diagnostic consideration rather than an established diagnosis. Option A uses the phrase “concern for,” which is a classic uncertainty qualifier and signals the provider is considering streptococcal pneumonia but has not definitively diagnosed it. In contrast, options B and D describe active treatment “for streptococcal pneumonia,” which implies the provider is managing the condition as a working diagnosis; however, in outpatient coding, treatment alone does not automatically make a diagnosis confirmed if the documentation still reflects uncertainty—CDI would look for explicit provider confirmation. Option C (“evidence of”) generally suggests supportive findings and is commonly interpreted as stronger than “concern for,” though CDI would still assess whether the provider has clearly stated a confirmed diagnosis in the assessment/plan. Therefore, the clearest uncertain descriptor is “concern for.”